Colorectal cancer is the third most common cancer worldwide and the second highest cause of death from cancer in the UK, yet if diagnosed early it is treatable. Anne Llewellyn explains the insurance ramifications
An article has just been published in The Lancet medical journal which showed that a certain type of screening between the ages of 55 and 64 can substantially reduce colorectal cancer incidence and mortality, and this is likely to be added to the existing UK colorectal cancer screening programme. April 2010 was also bowel cancer awareness month. Could this mean a rise in the detection of colorectal cancer, and what could this mean for underwriting and claims? The bowel is divided into two distinct parts which have a different structure and function; the small bowel (small intestine) and ...
To continue reading this article...
Join Professional Adviser for free
- Unlimited access to real-time news, industry insights and market intelligence
- Stay ahead of the curve with spotlights on emerging trends and technologies
- Receive breaking news stories straight to your inbox in the daily newsletters
- Make smart business decisions with the latest developments in regulation, investing retirement and protection
- Members-only access to the editor’s weekly Friday commentary
- Be the first to hear about our events and awards programmes